Comparative Analysis of Different DNA-Binding Drugs for Leishmaniasis Cure: A Pharmacoinformatics Approach

Abstract

Several experiments have been performed to test DNA-binding drugs to cure Leishmania infection. However, there are no details of pharmacoinformatics study. Herein, we have selected a good number of compounds from experimentally verified studies and performed a comparative analysis based on pharmacoinformatics techniques. In silico docking study was performed to observe the molecular level interactions of these known ligands with the DNA receptor by automated computational docking using Glide. A comparison between the calculated interaction energies and in silico ADME/T study was made. In agreement with drug likeness rules, our study suggests that seco-hydroxy-aza-CBI-TMI (compound 4b; GScore, -12.058) is a potential molecule for targeting the DNA to cure leishmaniasis. A comparative Pharmacoinformatics study including ADME/T was performed for DNA binding's drugs of Leishmania. © 2012 John Wiley & Sons A/S.